Skip to main content Accessibility help
  • Print publication year: 2015
  • Online publication date: February 2015

28 - A slim patient with polycystic ovary syndrome (PCOS)


1. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 2004; 19(1): 41–7.
2. Nastri CO, Ferriani RA, Rocha IA, Martins WP. Ovarian hyperstimulation syndrome: pathophysiology and prevention. Journal of Assisted Reproduction and Genetics 2010; 27(2–3): 121–8.
3. Wang JX, Davies MJ, Norman RJ. Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. Human Reproduction 2001; 16(12): 2606–9.
4. Eijkemans MJ, Habbema JD, Fauser BC. Characteristics of the best prognostic evidence: an example on prediction of outcome after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Semin Reprod Med 2003; 21(1): 39–47.
5. Humaidan P, Papanikolaou EG, Kyrou D, Alsbjerg B, Polyzos NP, Devroey P, Fatemi HM. The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives. Reproductive Biomedicine Online 2012; 24(2): 134–41.